Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2008
10/29/2008EP1984390A2 Methods for breeding glyphosate resistant plants and compositions thereof
10/29/2008EP1984389A1 Zmtcrr-1 plant signal transduction gene and promoter
10/29/2008EP1984388A2 Hpv antigens, vaccine compositions, and related methods
10/29/2008EP1984386A1 Methods for the synthesis of two or more dicarba bridges in organic compounds
10/29/2008EP1984384A1 Conotoxin analogues, and methods for synthesis of intramolecular dicarba bridge containing peptides
10/29/2008EP1984023A2 Soluble fragments of the sars-cov spike glycoprotein
10/29/2008EP1984019A1 Novel phosphopeptides and uses thereof in preventing kidney stone formation
10/29/2008EP1984015A2 Methods and compositions for treating asthma in human and non human primates
10/29/2008EP1984003A2 Therapeutic uses of inhibitors of rtp801
10/29/2008EP1750983A4 High protein soybean meal
10/29/2008EP1749026A4 Labelled adrenomedullin derivatives and their use for imaging and therapy
10/29/2008EP1737958B1 Compositions and methods for inducing anti-tumor immunity
10/29/2008EP1710251B1 Novel peptide, process for producing the same and pharmaceutical composition containing the peptide
10/29/2008EP1668129B1 Anti-angiogenic peptides from the n-terminus of endostatin
10/29/2008EP1589986B1 Methods and uses of the integrin alpha 10 chain, for diagnosing and detecting atherosclerosis plaque formation in vitro
10/29/2008EP1483399B1 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
10/29/2008EP1441764B1 Antigen arrays comprising rankl for treatment of bone disease
10/29/2008EP1372828A4 Biochips including ion transport detecting structures and methods of use
10/29/2008EP1334119B1 Compositions and methods for modulating rsv infection and immunity
10/29/2008EP1332207B1 Transformation systems for flavinogenic yeast
10/29/2008EP1297145B1 Streptococcus pyogenes antigen
10/29/2008EP1294771B1 Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
10/29/2008EP1234044B1 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides
10/29/2008EP1222208B1 Polypeptide derivatives of parathyroid hormone (pth)
10/29/2008EP1196607B1 Chlamysin b antibacterial protein, gene encoding it and an expression system for it
10/29/2008EP1180155B1 Vector for integration of heterologous sequences into poxviral genomes
10/29/2008EP1177299B1 Auxin transport proteins
10/29/2008EP1116791B1 Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
10/29/2008EP1071460B1 INTERNALIZING ErbB2 ANTIBODIES
10/29/2008EP1066390B1 Methods of cancer diagnosis using a chimeric toxin
10/29/2008EP1036180B1 Vaccine prepared with circovirus type b sequences related to piglet weight loss disease (pwd)
10/29/2008EP1017785B1 Rna export element
10/29/2008EP0961831B1 Human endokine alpha
10/29/2008EP0898580B3 Methods and means for inhibition of cdk4 activity
10/29/2008EP0846128B1 Antimicrobial cationic peptides and methods of screening for the same
10/29/2008EP0695351B2 Isolation, selection and propagation of animal transgenic stem cells other than embryonic stem cells
10/29/2008EP0660721B1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
10/29/2008CN101297034A Ply-gbs突变溶素 Ply-gbs mutant lysin
10/29/2008CN101296943A Killing human lymphoma and leukemia cancer cells and TCR-activated normal human cells by dopamine D1R agonists
10/29/2008CN101296942A Hybrid polypeptides with selectable properties
10/29/2008CN101296941A Interleukin-8 labelled via one or more site specifically conjugated hydrazinonicotinamide (HYNIC) moieties and its use in diagnosis of infection and inflammation
10/29/2008CN101296940A Peptides exhibiting efficacies of improvement in skin conditions or treatment of periodental diseases
10/29/2008CN101296708A 选择性vpac2受体肽激动剂 Vpac2 receptor selective agonist peptide
10/29/2008CN101294188A Lactoferrin antimicrobial peptide, preparing method and uses thereof
10/29/2008CN101294162A P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
10/29/2008CN101294160A Rice OsPT6:1 gene coded sequence and uses thereof
10/29/2008CN101293929A Preparation and application of natural polypeptide medicaments derivative
10/29/2008CN101293928A Preparation and application of genetic engineering synthetic polypeptide medicaments for treating tubercle bacillus infection contamination
10/29/2008CN101293927A Preparation and application of artificial synthetic polypeptide medicaments for treating tubercle bacillus infection contamination
10/29/2008CN101293926A Preparation and application of antimicrobial peptide medicaments for treating tubercle bacillus infection contamination
10/29/2008CN101293925A Preparation and application of synthetic polypeptide medicaments for treating tubercle bacillus infection contamination
10/29/2008CN101293924A Monoclone antibody with combined function epiposition, specificity of osteopontin and in preparing antineoplastic diversion medicaments
10/29/2008CN101293923A Agrocybe sp. antiviral protein and separation purification process
10/29/2008CN101293922A Streptococcus pneumoniae proteins and nucleic acid molecules
10/29/2008CN101293921A Streptococcus pneumoniae proteins and nucleic acid molecules
10/29/2008CN101293919A Syphilis spirochete membrane antigen with shorten expression and uses thereof
10/29/2008CN101293918A Shorten human papilloma virus 16 type L1 protein
10/29/2008CN101293097A Recombined staphylococcus aureus enterotoxin O oral preparation and application thereof
10/29/2008CN101293096A Recombined staphylococcus aureus enterotoxin N oral preparation and application thereof
10/29/2008CN101293095A Recombined staphylococcus aureus enterotoxin Q oral preparation and application thereof
10/29/2008CN101293094A Recombined staphylococcus aureus enterotoxin K oral preparation and application thereof
10/29/2008CN101293093A Recombined staphylococcus aureus enterotoxin M oral preparation and application thereof
10/29/2008CN101293092A Recombined staphylococcus aureus enterotoxin I oral preparation and application thereof
10/29/2008CN100429315C Expression vectors comprising the MCMV IE2 promoter
10/29/2008CN100429234C Compounds and methods of early diagnosis of cervical cancer and genital condyloma with hpv, chsp60 tumor suppressor h-ras, k-ras and pten derived peptides modified
10/29/2008CN100429230C Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
10/29/2008CN100429229C Jingzhao toxin V
10/29/2008CN100429228C Recombination human A20 protein and its uses
10/29/2008CN100429227C Exendin 4 polypeptide segment
10/29/2008CN100429226C Novel process for genetic engineering preparation of insulin and insulin analogs
10/29/2008CN100429225C Promyostatin peptides and methods of using same
10/29/2008CN100429224C Antitumor activity of squash protein and use thereof
10/28/2008US7442864 Soybean cultivar 6326393
10/28/2008US7442863 Soybean cultivar 6434385
10/28/2008US7442862 Soybean cultivar S060295
10/28/2008US7442860 Soybean cultivar 6421326
10/28/2008US7442784 For regulation of gene expression
10/28/2008US7442782 Intron associated with myotonic dystrophy type 2 and methods of use
10/28/2008US7442775 Humanized anti-CCR2 antibodies and methods of use therefor
10/28/2008US7442774 INGAP displacement assays
10/28/2008US7442773 Biological scaffold comprising src, major histocompatibility and/or pdz domains for use as diagnostic tool in detection of metabolic disorders
10/28/2008US7442770 Human clnk-related polypeptide, MIST (Mast Cell Immunoreceptor Signal Transducer)
10/28/2008US7442769 Antifreeze proteins from basidiomy cetes
10/28/2008US7442768 amino acid sequences that can be used as in vivo fluorescent markers which can be expressed in host cells in in vitro cultures using mammal cells
10/28/2008US7442767 α1D calcium channel expressed in atrium
10/28/2008US7442766 Pfu replication accessory factors and methods of use
10/28/2008US7442765 PRO polypeptides; fused to heterologous polypeptide sequences
10/28/2008US7442763 Kidney diseases
10/28/2008US7442762 peptide antibiotics comprising polypeptides having detectable chromogens, fluorescent and cyanine dyes,and replacements in the amino acid sequence; capable of inhibiting bacterial cell growth by binding to RNA polymerases
10/28/2008US7442761 Coronavirus amino acid sequences for use in prevention and treatment of infection and cell proliferative disorders
10/28/2008US7442688 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
10/28/2008US7442686 Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
10/28/2008US7442682 disclosed for the treatment of diabetes and related diseases using peptides with incretin hormone activity. Preferably, the peptide with incretin hormone activity is GLP-1, exendin or an analog of GLP-1 or exendin. The peptides with incretin hormone activity are administered transepithelially hormones
10/28/2008US7442551 Lentiviral packaging constructs
10/28/2008US7442550 Detection is established by the fusogenic power of the polypeptide, which is demonstrated by syncytia formation; use in drug testing or drug screening; HERV-W envelope glycoprotein; cancer gene therapy
10/28/2008US7442544 Viral vector in which gene for Sendai viral protein selected from NP, P, and L proteins is deleted or inactivated while all other gene functions are retained; use as expression vector in e.g. gene therapy; efficient system for reconstituting Sendai virus
10/28/2008US7442543 Nucleotide sequences coding selenium containing protein for use in diagnosis, prevention and treatment prostate cell proliferative disorders
10/28/2008US7442540 Polynucleotide encoding coleopteran-toxic polypeptide
10/28/2008US7442536 proteins is "cysteinized" to permit easier conjugation to a targeting moiety
10/28/2008US7442535 Fusion protein incorporating a cysteinized ribonuclease
1 ... 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 ... 2916